PlantForm Overview

  • Founded

  • 2008

Founded
  • Status

  • Private

  • Employees

  • 24

Employees
  • Latest Deal Type

  • Grant

  • Latest Deal Amount

  • $25K

  • Investors

  • 10

PlantForm General Information

Description

Developer of antibody and protein drugs designed to assist in cancer treatment. The company's products use mammalian and bacterial cell culture systems to produce recombinant protein pharmaceuticals including monoclonal antibodies, therapeutic proteins and vaccines, enabling physicians to treat cancer, Ebola virus and other life-threatening illnesses.

Contact Information

Website
www.plantformcorp.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1920 Yonge Street
  • Suite 200
  • Toronto, Ontario M4S 3E2
  • Canada
+1 (416) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PlantForm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 27-Feb-2018 $25K 00.00 Completed Generating Revenue
11. Grant 12-Dec-2016 00000 00.00 Completed Generating Revenue
10. Grant 04-Jan-2016 00.00 Completed Generating Revenue
9. Grant 28-Oct-2015 00000 00.00 Completed Generating Revenue
8. Grant 31-Mar-2015 00000 00.00 Completed Generating Revenue
7. Grant 22-Dec-2014 00.00 Completed Generating Revenue
6. Grant 16-May-2014 0000 00.00 Completed Generating Revenue
5. Later Stage VC 20-Aug-2013 000 00.00 0000 Completed Clinical Trials - Phase 1
4. Grant 12-Aug-2013 $2.26M $1.5M Completed Startup
3. Grant 26-Dec-2011 $840K $1.5M Completed Startup
To view PlantForm’s complete valuation and funding history, request access »

PlantForm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody and protein drugs designed to assist in cancer treatment. The company's products use mammalian and
Drug Discovery
Toronto, Canada
24 As of 2023
00.00
0000000000 00.00

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
0000 000000000
Boston, MA
0000 As of 0000
00.000
000 0000-00-00
000000&0

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
0000 000000000
Marina del Rey, CA
00 As of 0000
00000
000 0000-00-00
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PlantForm Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vertex Pharmaceuticals Formerly VC-backed Boston, MA 0000 00.000 000000&0
000000 00000000000 Formerly VC-backed Marina del Rey, CA 00 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, United Kingdom 000 00000 000000000 00000
00000000 Venture Capital-Backed San Francisco, CA 00 00000 0000000000 00000
000000 00000000000 Formerly VC-backed Los Gatos, CA 00 000.00 000000000 000.00
You’re viewing 5 of 23 competitors. Get the full list »

PlantForm Patents

  • 13

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

PlantForm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3132423-A1 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 00000000000
EP-3935180-A1 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 00000000000
EP-3935180-A4 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 00000000000 0
US-20220135992-A1 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 00000000000
CA-3071578-A1 Transient silencing of argonaute1 and argonaute4 to increase recombinant protein expression in plants Pending 03-Aug-2017 C12N15/8218
To view PlantForm’s complete patent history, request access »

PlantForm Executive Team (7)

Name Title Board Seat Contact Info
Donald Stewart Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Ronald Hosking Co-Founder, Chairman & Chief Financial Officer
David Cayea Chief Operating Officer
Mark Goldberg Co-Founder & Board Member
Doug Cossar Vice President, Research and Chair of the Scientific Advisory Board
You’re viewing 5 of 7 executive team members. Get the full list »

PlantForm Board Members (8)

Name Representing Role Since
David Fraser PlantForm Board Member 000 0000
Donald Stewart Ph.D PlantForm Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Doug Cossar PlantForm Vice President, Research and Chair of the Scientific Advisory Board 000 0000
Mark Goldberg PlantForm Co-Founder & Board Member 000 0000
Ronald Hosking PlantForm Co-Founder, Chairman & Chief Financial Officer 000 0000
You’re viewing 5 of 8 board members. Get the full list »

PlantForm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PlantForm Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Natural Sciences and Engineering Research Council of Canada Government 000 0000 000000 0
NSERC-Engage Government 000 0000 000000 0
Government of Canada Government 000 0000 000000 0
Atlantic Assets Trust Corporation Minority 000 0000 000000 0
Defense Advanced Research Projects Agency Government 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

PlantForm Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 01-Jan-2014 00000 0000 Biotechnology
To view PlantForm’s complete investments history, request access »

Ready to get started?

Request a free trial